If I have to guess cldx stock will react positively as it did just that when last time I thought the pfs data were underwhelming. I am a good contrarian indicator. Stage iv/metastatic disease is not a prognostic factor. all patients in this setting are stage iv or m1 disease.
Market Data 
Markets 
AI
